Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Active Comparator Study of Generex Oral-lyn™ Spray and Injected Human Insulin

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
OSMOS Clinical Research, Inc
PSI Pharma Support Intl
Nextrials, Inc.
eResearch Technology, Inc.
Hoffmann-La Roche
ACM Pivotal Global Central Laboratory
Information provided by:
Generex Biotechnology Corp.
ClinicalTrials.gov Identifier:
NCT00668850
First received: April 24, 2008
Last updated: June 6, 2011
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2011
  Estimated Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)